{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:45:27Z","timestamp":1785527127786,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Municipal Commission of Science and Technology","award":["24JS2850100"],"award-info":[{"award-number":["24JS2850100"]}]},{"name":"National Clinical Key Specialty Construction Project","award":["10000015Z155080000004"],"award-info":[{"award-number":["10000015Z155080000004"]}]},{"name":"Top-notch Talents Project of Shanghai Municipal Oriental Elite Program","award":["BJW2025031"],"award-info":[{"award-number":["BJW2025031"]}]},{"name":"\"Pioneer\" and \"Leading Goose\" R&D Program of Zhejiang Province","award":["2024C03181"],"award-info":[{"award-number":["2024C03181"]}]},{"name":"Incubation Project of \"Medicine+X\" Interdisciplinary Innovation Team of Children's Hospital of Fudan University","award":["PT000384"],"award-info":[{"award-number":["PT000384"]}]},{"DOI":"10.13039\/100012515","name":"Cyrus Tang Foundation","doi-asserted-by":"publisher","award":["ZSBK0070"],"award-info":[{"award-number":["ZSBK0070"]}],"id":[{"id":"10.13039\/100012515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00837-w","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:16:10Z","timestamp":1779876970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual inhibition of KDM4B and KDM5A disassembles the PAX3-FOXO1 transcriptional program in fusion-positive rhabdomyosarcoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Junhong","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"11","key":"837_CR1","doi-asserted-by":"publisher","first-page":"a025650","DOI":"10.1101\/cshperspect.a025650","volume":"4","author":"S Hettmer","year":"2014","unstructured":"Hettmer S, Li Z, Billin AN, Barr FG, Cornelison DD, Ehrlich AR, et al. Rhabdomyosarcoma: current challenges and their implications for developing therapies. Cold Spring Harb Perspect Med. 2014;4(11):a025650.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"837_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0051-2","volume":"5","author":"SX Skapek","year":"2019","unstructured":"Skapek SX, Ferrari A, Gupta AA, Lupo PJ, Butler E, Shipley J, et al. Rhabdomyosarcoma Nat Rev Dis Primers. 2019;5(1):1.","journal-title":"Rhabdomyosarcoma Nat Rev Dis Primers"},{"issue":"40","key":"837_CR3","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1038\/sj.onc.1204599","volume":"20","author":"FG Barr","year":"2001","unstructured":"Barr FG. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene. 2001;20(40):5736\u201346.","journal-title":"Oncogene"},{"issue":"1","key":"837_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2008.03.035","volume":"270","author":"CM Linardic","year":"2008","unstructured":"Linardic CM. PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett. 2008;270(1):10\u20138.","journal-title":"Cancer Lett"},{"issue":"14","key":"837_CR5","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1101\/gad.238733.114","volume":"28","author":"J Abraham","year":"2014","unstructured":"Abraham J, Nu\u00f1ez-\u00c1lvarez Y, Hettmer S, Carri\u00f3 E, Chen HI, Nishijo K, et al. Lineage of origin in rhabdomyosarcoma informs pharmacological response. Genes Dev. 2014;28(14):1578\u201391.","journal-title":"Genes Dev"},{"issue":"9","key":"837_CR6","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/pbc.24532","volume":"60","author":"SX Skapek","year":"2013","unstructured":"Skapek SX, Anderson J, Barr FG, Bridge JA, Gastier-Foster JM, Parham DM, et al. PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children\u2019s oncology group report. Pediatr Blood Cancer. 2013;60(9):1411\u20137.","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"837_CR7","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1200\/JCO.2002.03.137","volume":"20","author":"PH Sorensen","year":"2002","unstructured":"Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children\u2019s oncology group. J Clin Oncol. 2002;20(11):2672\u20139.","journal-title":"J Clin Oncol"},{"issue":"10","key":"837_CR8","doi-asserted-by":"publisher","first-page":"e27869","DOI":"10.1002\/pbc.27869","volume":"66","author":"ME Yohe","year":"2019","unstructured":"Yohe ME, Heske CM, Stewart E, Adamson PC, Ahmed N, Antonescu CR, et al. Insights into pediatric rhabdomyosarcoma research: Challenges and goals. Pediatr Blood Cancer. 2019;66(10):e27869.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"837_CR9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1158\/2159-8290.CD-16-1297","volume":"7","author":"BE Gryder","year":"2017","unstructured":"Gryder BE, Yohe ME, Chou HC, Zhang X, Marques J, Wachtel M, et al. PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability. Cancer Discov. 2017;7(8):884\u201399.","journal-title":"Cancer Discov"},{"issue":"12","key":"837_CR10","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41588-019-0534-4","volume":"51","author":"BE Gryder","year":"2019","unstructured":"Gryder BE, Pomella S, Sayers C, Wu XS, Song Y, Chiarella AM, et al. Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma. Nat Genet. 2019;51(12):1714\u201322.","journal-title":"Nat Genet"},{"issue":"1","key":"837_CR11","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1038\/s41467-019-11046-7","volume":"10","author":"BE Gryder","year":"2019","unstructured":"Gryder BE, Wu L, Woldemichael GM, Pomella S, Quinn TR, Park PMC, et al. Chemical genomics reveals histone deacetylases are required for core regulatory transcription. Nat Commun. 2019;10(1):3004.","journal-title":"Nat Commun"},{"issue":"2","key":"837_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00280-018-3615-7","volume":"82","author":"M Wierdl","year":"2018","unstructured":"Wierdl M, Tsurkan L, Chi L, Hatfield MJ, Tollemar V, Bradley C, et al. Targeting ALK in pediatric RMS does not induce antitumor activity in vivo. Cancer Chemother Pharmacol. 2018;82(2):251\u201363.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"837_CR13","doi-asserted-by":"publisher","first-page":"e76551","DOI":"10.1371\/journal.pone.0076551","volume":"8","author":"SQ Li","year":"2013","unstructured":"Li SQ, Cheuk AT, Shern JF, Song YK, Hurd L, Liao H, et al. Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534). PLoS ONE. 2013;8(10):e76551.","journal-title":"PLoS ONE"},{"issue":"1","key":"837_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/1389450117666151209124123","volume":"18","author":"B Szewczyk","year":"2017","unstructured":"Szewczyk B, Skrzypek K, Majka M. Targeting MET Receptor in Rhabdomyosarcoma: Rationale and Progress. Curr Drug Targets. 2017;18(1):98\u2013107.","journal-title":"Curr Drug Targets"},{"key":"837_CR15","doi-asserted-by":"crossref","unstructured":"Nguyen TH, Barr FG. Therapeutic approaches targeting PAX3-FOXO1 and Its regulatory and transcriptional pathways in rhabdomyosarcoma. Molecules. 2018;23(11).","DOI":"10.3390\/molecules23112798"},{"issue":"16","key":"837_CR16","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1002\/cncr.28728","volume":"120","author":"AS Pappo","year":"2014","unstructured":"Pappo AS, Vassal G, Crowley JJ, Bolejack V, Hogendoorn PC, Chugh R, et al. A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study. Cancer. 2014;120(16):2448\u201356.","journal-title":"Cancer"},{"issue":"11","key":"837_CR17","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1101\/gad.280495.116","volume":"30","author":"K Agger","year":"2016","unstructured":"Agger K, Miyagi S, Pedersen MT, Kooistra SM, Johansen JV, Helin K. Jmjd2\/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells. Genes Dev. 2016;30(11):1278\u201388.","journal-title":"Genes Dev"},{"issue":"3","key":"837_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ccell.2018.01.018","volume":"33","author":"A Banito","year":"2018","unstructured":"Banito A, Li X, Laporte AN, Roe JS, Sanchez-Vega F, Huang CH, et al. The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Cancer Cell. 2018;33(3):527\u2013e418.","journal-title":"Cancer Cell"},{"issue":"4","key":"837_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ccr.2012.03.014","volume":"21","author":"WJ Harris","year":"2012","unstructured":"Harris WJ, Huang X, Lynch JT, Spencer GJ, Hitchin JR, Li Y, et al. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell. 2012;21(4):473\u201387.","journal-title":"Cancer Cell"},{"issue":"1","key":"837_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ccell.2015.12.007","volume":"29","author":"N Cheung","year":"2016","unstructured":"Cheung N, Fung TK, Zeisig BB, Holmes K, Rane JK, Mowen KA, et al. Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia. Cancer Cell. 2016;29(1):32\u201348.","journal-title":"Cancer Cell"},{"issue":"47","key":"837_CR21","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.1038\/onc.2016.142","volume":"35","author":"S Sankar","year":"2016","unstructured":"Sankar S, Bell R, Stephens B, Zhuo R, Sharma S, Bearss DJ, et al. Mechanism and relevance of EWS\/FLI-mediated transcriptional repression in Ewing sarcoma. Oncogene. 2016;35(47):6155\u20136.","journal-title":"Oncogene"},{"issue":"653","key":"837_CR22","doi-asserted-by":"publisher","first-page":"eabq2096","DOI":"10.1126\/scitranslmed.abq2096","volume":"14","author":"S Singh","year":"2022","unstructured":"Singh S, Abu-Zaid A, Jin H, Fang J, Wu Q, Wang T, et al. Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma. Sci Transl Med. 2022;14(653):eabq2096.","journal-title":"Sci Transl Med"},{"issue":"1","key":"837_CR23","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41467-024-45902-y","volume":"15","author":"YY Kim","year":"2024","unstructured":"Kim YY, Gryder BE, Sinniah R, Peach ML, Shern JF, Abdelmaksoud A, et al. KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma. Nat Commun. 2024;15(1):1703.","journal-title":"Nat Commun"},{"issue":"6","key":"837_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ccr.2013.11.002","volume":"24","author":"X Chen","year":"2013","unstructured":"Chen X, Stewart E, Shelat AA, Qu C, Bahrami A, Hatley M, et al. Targeting oxidative stress in embryonal rhabdomyosarcoma. Cancer Cell. 2013;24(6):710\u201324.","journal-title":"Cancer Cell"},{"issue":"2","key":"837_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1158\/2159-8290.CD-13-0639","volume":"4","author":"JF Shern","year":"2014","unstructured":"Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, Rosenberg M, et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov. 2014;4(2):216\u201331.","journal-title":"Cancer Discov"},{"issue":"2","key":"837_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1021\/ci900419k","volume":"50","author":"H Geppert","year":"2010","unstructured":"Geppert H, Vogt M, Bajorath J. Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation. J Chem Inf Model. 2010;50(2):205\u201316.","journal-title":"J Chem Inf Model"},{"issue":"40","key":"837_CR27","doi-asserted-by":"publisher","first-page":"e2403998","DOI":"10.1002\/advs.202403998","volume":"11","author":"L Wang","year":"2024","unstructured":"Wang L, Wang S, Yang H, Li S, Wang X, Zhou Y, et al. Conformational Space Profiling Enhances Generic Molecular Representation for AI-Powered Ligand-Based Drug Discovery. Adv Sci (Weinh). 2024;11(40):e2403998.","journal-title":"Adv Sci (Weinh)"},{"key":"837_CR28","doi-asserted-by":"crossref","unstructured":"Wang SH, HQL, Qin WC, et al. PhenoModel: A multimodal phenotypic drug design foundation model for discovering novel potential inhibitors of multiple cancer cells. Acta Pharm Sinica B. 2025.","DOI":"10.1016\/j.apsb.2025.09.036"},{"issue":"6\u20137","key":"837_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","volume":"24","author":"JR Greenwood","year":"2010","unstructured":"Greenwood JR, Calkins D, Sullivan AP, Shelley JC. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution. J Comput Aided Mol Des. 2010;24(6\u20137):591\u2013604.","journal-title":"J Comput Aided Mol Des"},{"issue":"11","key":"837_CR30","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.1021\/acs.jctc.1c00810","volume":"17","author":"Y Yang","year":"2021","unstructured":"Yang Y, Yao K, Repasky MP, Leswing K, Abel R, Shoichet BK, et al. Efficient Exploration of Chemical Space with Docking and Deep Learning. J Chem Theory Comput. 2021;17(11):7106\u201319.","journal-title":"J Chem Theory Comput"},{"issue":"43","key":"837_CR31","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"837_CR32","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","volume":"20","author":"LG Ferreira","year":"2015","unstructured":"Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. 2015;20(7):13384\u2013421.","journal-title":"Molecules"},{"issue":"3","key":"837_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cell.2006.03.028","volume":"125","author":"JR Whetstine","year":"2006","unstructured":"Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell. 2006;125(3):467\u201381.","journal-title":"Cell"},{"issue":"5","key":"837_CR34","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.cell.2007.02.013","volume":"128","author":"RJ Klose","year":"2007","unstructured":"Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, Tempst P, et al. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell. 2007;128(5):889\u2013900.","journal-title":"Cell"},{"issue":"7163","key":"837_CR35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nature06192","volume":"449","author":"F Lan","year":"2007","unstructured":"Lan F, Bayliss PE, Rinn JL, Whetstine JR, Wang JK, Chen S, et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature. 2007;449(7163):689\u201394.","journal-title":"Nature"},{"issue":"4","key":"837_CR36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cell.2006.04.024","volume":"125","author":"Z Chen","year":"2006","unstructured":"Chen Z, Zang J, Whetstine J, Hong X, Davrazou F, Kutateladze TG, et al. Structural insights into histone demethylation by JMJD2 family members. Cell. 2006;125(4):691\u2013702.","journal-title":"Cell"},{"issue":"1","key":"837_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12943-024-02197-3","volume":"23","author":"X Li","year":"2024","unstructured":"Li X, Zhang Z, Li Y, Chen L, Huang Y, Su L, et al. Mutation of lysine-specific demethylase 5 is associated with enhanced tumor immunity and favorable outcomes in pan-cancer immune checkpoint blockade. Mol Cancer. 2024;23(1):281.","journal-title":"Mol Cancer"},{"issue":"1","key":"837_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12943-024-02011-0","volume":"23","author":"CY Li","year":"2024","unstructured":"Li CY, Wang W, Leung CH, Yang GJ, Chen J. KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges. Mol Cancer. 2024;23(1):109.","journal-title":"Mol Cancer"},{"issue":"6","key":"837_CR39","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1158\/2159-8290.CD-22-0825","volume":"13","author":"K Gunn","year":"2023","unstructured":"Gunn K, Myllykoski M, Cao JZ, Ahmed M, Huang B, Rouaisnel B, et al. (R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-Mutant Cancers. Cancer Discov. 2023;13(6):1478\u201397.","journal-title":"Cancer Discov"},{"issue":"12","key":"837_CR40","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/s12276-022-00902-0","volume":"54","author":"J Yoo","year":"2022","unstructured":"Yoo J, Kim GW, Jeon YH, Kim JY, Lee SW, Kwon SH. Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis. Exp Mol Med. 2022;54(12):2107\u201317.","journal-title":"Exp Mol Med"},{"issue":"4","key":"837_CR41","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/2643-3230.BCD-20-0108","volume":"2","author":"H Ohguchi","year":"2021","unstructured":"Ohguchi H, Park PMC, Wang T, Gryder BE, Ogiya D, Kurata K, et al. Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma. Blood Cancer Discov. 2021;2(4):370\u201387.","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"837_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"837_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 1999;27(1):29\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"837_CR44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nchembio.2085","volume":"12","author":"M Vinogradova","year":"2016","unstructured":"Vinogradova M, Gehling VS, Gustafson A, Arora S, Tindell CA, Wilson C, et al. An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells. Nat Chem Biol. 2016;12(7):531\u20138.","journal-title":"Nat Chem Biol"},{"key":"837_CR45","doi-asserted-by":"crossref","unstructured":"Zhang S, Wang J, Liu Q, McDonald WH, Bomber ML, Layden HM, et al. PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets. Mol Cell. 2022;82(23):4428-42.e7.","DOI":"10.1016\/j.molcel.2022.10.025"},{"issue":"15","key":"837_CR46","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1158\/0008-5472.CAN-12-3165","volume":"73","author":"YC Teng","year":"2013","unstructured":"Teng YC, Lee CF, Li YS, Chen YR, Hsiao PW, Chan MY, et al. Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis. Cancer Res. 2013;73(15):4711\u201321.","journal-title":"Cancer Res"},{"issue":"6","key":"837_CR47","doi-asserted-by":"publisher","first-page":"djv080","DOI":"10.1093\/jnci\/djv080","volume":"107","author":"J Yang","year":"2015","unstructured":"Yang J, AlTahan AM, Hu D, Wang Y, Cheng PH, Morton CL, et al. The role of histone demethylase KDM4B in Myc signaling in neuroblastoma. J Natl Cancer Inst. 2015;107(6):djv080.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"837_CR48","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.celrep.2014.02.004","volume":"6","author":"J Cao","year":"2014","unstructured":"Cao J, Liu Z, Cheung WK, Zhao M, Chen SY, Chan SW, et al. Histone demethylase RBP2 is critical for breast cancer progression and metastasis. Cell Rep. 2014;6(5):868\u201377.","journal-title":"Cell Rep"},{"issue":"45","key":"837_CR49","doi-asserted-by":"publisher","first-page":"18499","DOI":"10.1073\/pnas.1216724109","volume":"109","author":"ML Beshiri","year":"2012","unstructured":"Beshiri ML, Holmes KB, Richter WF, Hess S, Islam AB, Yan Q, et al. Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation. Proc Natl Acad Sci U S A. 2012;109(45):18499\u2013504.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"837_CR50","doi-asserted-by":"publisher","first-page":"906662","DOI":"10.3389\/fgene.2022.906662","volume":"13","author":"E Pavlenko","year":"2022","unstructured":"Pavlenko E, Ruengeler T, Engel P, Poepsel S. Functions and Interactions of Mammalian KDM5 Demethylases. Front Genet. 2022;13:906662.","journal-title":"Front Genet"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00837-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00837-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00837-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:09:04Z","timestamp":1785521344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00837-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00837-w","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have agreed to the content of the manuscript and agree to this submission.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"134"}}